Higher serum levels of autotaxin and phosphatidylserine-specific phospholipase A
ATX
PS-PLA1
lupus nephritis
pathology
Journal
International journal of rheumatic diseases
ISSN: 1756-185X
Titre abrégé: Int J Rheum Dis
Pays: England
ID NLM: 101474930
Informations de publication
Date de publication:
Feb 2021
Feb 2021
Historique:
received:
29
06
2020
revised:
03
11
2020
accepted:
07
11
2020
pubmed:
15
12
2020
medline:
4
11
2021
entrez:
14
12
2020
Statut:
ppublish
Résumé
Recent studies revealed that lysophospholipids (LPLs) and related molecules, such as autotaxin (ATX) and phosphatidylserine-specific phospholipase A In this retrospective cohort study, serum samples were collected from 39 patients with LN and 37 patients with other glomerular diseases. The serum levels of ATX and PS-PLA The serum levels of ATX and PS-PLA Although the serum levels of ATX and PS-PLA
Sections du résumé
BACKGROUND
BACKGROUND
Recent studies revealed that lysophospholipids (LPLs) and related molecules, such as autotaxin (ATX) and phosphatidylserine-specific phospholipase A
METHODS
METHODS
In this retrospective cohort study, serum samples were collected from 39 patients with LN and 37 patients with other glomerular diseases. The serum levels of ATX and PS-PLA
RESULTS
RESULTS
The serum levels of ATX and PS-PLA
CONCLUSION
CONCLUSIONS
Although the serum levels of ATX and PS-PLA
Identifiants
pubmed: 33314787
doi: 10.1111/1756-185X.14031
doi:
Substances chimiques
Biomarkers
0
PLA1A protein, human
EC 3.1.1.32
Phospholipases A1
EC 3.1.1.32
Phosphoric Diester Hydrolases
EC 3.1.4.-
alkylglycerophosphoethanolamine phosphodiesterase
EC 3.1.4.39
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
231-239Informations de copyright
© 2020 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.
Références
Jakes RW, Bae SC, Louthrenoo W, Mok CC, Navarra SV, Kwon N. Systematic review of the epidemiology of systemic lupus erythematosus in the Asia-Pacific region: prevalence, incidence, clinical features, and mortality. Arthritis Care Res. 2012;64(2):159-168.
Yokoyama H, Wada T, Hara A, et al. The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese. Kidney Int. 2004;66(6):2382-2388.
Alarcón GS. Multiethnic lupus cohorts: what have they taught us? Reumatol Clin. 2011;7:3-6.
Soliman S, Mohan C. Lupus nephritis biomarkers. Clin Immunol. 2017;185:10-20.
Trayssac M, Hannun YA, Obeid LM. Role of sphingolipids in senescence: implication in aging and age-related diseases. J Clin Invest. 2018;128(7):2702-2712.
Lee D, Suh DS, Lee SC, Tigyi GJ, Kim JH. Role of autotaxin in cancer stem cells. Cancer Metastasis Rev. 2018;37(2-3):509-518.
Kurano M, Yatomi Y. Sphingosine 1-Phosphate and Atherosclerosis. J Atheroscler Thromb. 2018;25(1):16-26.
Ng ML, Wadham C, Sukocheva OA. The role of sphingolipid signalling in diabetes-associated pathologies (Review). Int J Mol Med. 2017;39(2):243-252.
Kurano M, Miyagaki T, Miyagawa T, et al. Association between serum autotaxin or phosphatidylserine-specific phospholipase A1 levels and melanoma. J Dermatol. 2018;45(5):571-579.
Igarashi N, Honjo M, Kurano M, et al. Increased aqueous autotaxin and lysophosphatidic acid levels are potential prognostic factors after trabeculectomy in different types of glaucoma. Sci Rep. 2018;8(1):11304.
Shimizu M, Furuichi K, Toyama T, et al. Serum autotaxin levels are associated with proteinuria and kidney lesions in Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy. Intern Med. 2016;55(3):215-221.
Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271-1277.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum. 1997;40:1725.
Nakawatari K, Kurano M, Araki O, et al. Elevated phosphatidylserine-specific phospholipase A1 level in hyperthyroidism. Clin Chim Acta. 2020;503:99-106.
Nojiri T, Kurano M, Araki O, et al. Serum autotaxin levels are associated with Graves' disease. Endocr J. 2019;66(5):409-422.
Bajema IM, Wilhelmus S, Alpers CE, et al. Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices. Kidney Int. 2018;93(4):789-796.
Nakamura K, Igarashi R, Ohkawa N, et al. A novel enzyme immunoassay for the determination of phosphatidylserine-specific phospholipase A(1) in human serum samples. Clin Chim Acta. 2010;411:1090-1094.
Nakamura K, Igarashi K, Ide K, et al. Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. Clin Chim Acta. 2008;388(1-2):51-58.
Austin HA 3rd, Muenz LR, Joyce KM, Antonovych TT, Balow JE. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int. 1984;25(4):689-695.
Morel-Maroger L, Méry JP, Droz D, et al. The course of lupus nephritis: contribution of serial renal biopsies. Adv Nephrol Necker Hosp. 1976;6:79-118.
Moroni G, Vercelloni PG, Quaglini S, et al. Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis. Ann Rheum Dis. 2018;77(9):1318-1325.
Poissonnier A, Sanséau D, Le Gallo M, et al. CD95-mediated calcium signaling promotes T helper 17 trafficking to inflamed organs in lupus-prone mice. Immunity. 2016;45(1):209-223.
Luo B, Gan W, Liu Z, et al. Erythropoeitin signaling in macrophages promotes dying cell clearance and immune tolerance. Immunity. 2016;44(2):287-302.
Mohammed S, Vineetha NS, James S, et al. Regulatory role of SphK1 in TLR7/9-dependent type I interferon response and autoimmunity. FASEB J. 2020;34(3):4329-4347.
Checa A, Idborg H, Zandian A, et al. Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study. Lupus. 2017;26(10):1023-1033.
Sumida H, Nakamura K, Yanagida K, et al. Decrease in circulating autotaxin by oral administration of prednisolone. Clin Chim Acta. 2013;16(415):74-80.
Fukiage A, Fujino H, Miki D, et al. Clinical usefulness of serum autotaxin for early prediction of relapse in male patients with type 1 autoimmune pancreatitis. Dig Dis Sci. 2020. https://doi.org/10.1007/s10620-020-06338-8.
van Meeteren LA, Ruurs P, Christodoulou E, et al. Inhibition of autotaxin by lysophosphatidic acid and sphingosine 1-phosphate. J Biol Chem. 2005;280(22):21155-21161.
Benesch MG, Zhao YY, Curtis JM, McMullen TP, Brindley DN. Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate. J Lipid Res. 2015;56(6):1134-1144.
Sawada T, Kurano M, Shirai H, et al. Serum phosphatidylserine-specific phospholipase A1 as a novel biomarker for monitoring systemic lupus erythematosus disease activity. Int J Rheum Dis. 2019;22(11):2059-2066.
Yatomi Y, Kurano M, Ikeda H, Igarashi K, Kano K. Aoki J Lysophospholipids in laboratory medicine. Proc Jpn Acad Ser B Phys Biol Sci. 2018;94(10):373-389.